Indiana Seed Fund II Launches
Indiana-based BioCrossroads has launched an $8.25m early-stage capital fund focused on identifying, creating and developing life sciences companies. A follow-on to a $6m first fund, Indiana Seed Fund II will invest an average of $500k in early-stage biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech and health information technology products and platforms. It will be managed by […]